|
|
 | | | |
- close
- close
- close
- close
QUOTE AND NEWS
Marketwire
May 18
Comment
TORONTO, ONTARIO -- (Marketwire) -- 05/18/12 -- Compugen today announced that it has taken top spot in the Computer Dealer News (CDN) annual ranking of Canadian IT solution providers by revenue. Compugen's 2011 first-place results-a first for the
StreetInsider.com
May 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Compugen+Ltd+%28CGEN%29+Doubles+Q1+Loss+to+12cShare/7387068.html for the full story.
Business Wire
May 1
Comment
Compugen Ltd. (NASDAQ: CGEN) today reported financial results for the first quarter ending March 31, 2012. Anat Cohen-Dayag, Ph.D., President and CEO of Compugen, stated, “We were very pleased to announce this past quarter the establishment of
Benzinga
Apr 24
Comment
Compugen Ltd. (NASDAQ: CGEN) today reported the initial validation of two additional therapeutic product candidates, CGEN-15031 and CGEN-15051, in animal models of autoimmune diseases. These two novel molecules are soluble proteins based on two...
Business Wire
Apr 23
Comment
Compugen Ltd. (NASDAQ: CGEN) announced today that Dr. Mary Haak-Frendscho, Compugen Inc.'s Executive Chairperson of the Board, will deliver the keynote address at the 7th International China Pharmaceutical R&D Summit, on April 24, 2012 in Shanghai,
Business Wire
Apr 23
Comment
Compugen Ltd. (NASDAQ: CGEN) today announced that the Company will host a conference call at 10:00 AM EST on Tuesday, May 1, 2012 to review first quarter 2012 results. The quarterly results will be released on the Company’s website (www.cgen.com),
Marketwire
Apr 19
Comment
TORONTO, ONTARIO -- (Marketwire) -- 04/19/12 -- Compugen announced it has been named as CommVault's Support Partner of the Year in CommVault's worldwide PartnerAdvantage(TM) Awards. The CommVault PartnerAdvantage(TM) Awards recognize partners that
Compugen Establishes Operations in California for Development of Monoclonal Antibody Drug Candidates
Business Wire
Mar 28
Comment
Compugen Ltd. (NASDAQ: CGEN) announced today the establishment of operations in South San Francisco, California for the development of oncology and immunology monoclonal antibody (mAb) drug candidates against Compugen-discovered targets. The mission
Marketwire
Feb 16
Comment
TORONTO, ONTARIO -- (Marketwire) -- 02/16/12 -- Compugen today announced it has been again recognized as an esteemed HP Partner in Excellence, this time for Global Business Growth, at the 2012 HP Global Partner Conference (GPC) in Las Vegas, Nevada.
Marketwire
Feb 15
Comment
TORONTO, ONTARIO -- (Marketwire) -- 02/15/12 -- Compugen today announced that it has been recognized with an esteemed HP Partner in Excellence Canada ESSN Growth Award at the 2012 HP Global Partner Conference (GPC) in Las Vegas, Nevada. Selected by a
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
